[Event Report] Roundtable – The Increasing Role of Japanese Pharmaceutical Companies in Global Health (December 11, 2018)
date : 1/7/2019
Tags: Global Health, Other activities
HGPI convened a roundtable on “The Increasing Role of Japanese Pharmaceutical Companies in Global Health.” This meeting was held in accordance with online publication of “Access to Medicine Index 2018” by the Access to Medicine Foundation (published on November 20, 2018).
The roundtable was jointly hosted by the Access to Medicine Foundation, the Health and Global Policy Institute (HGPI), and the Japan International Cooperation Agency (JICA). Support was also provided by the Japanese Ministry of Foreign Affairs (MOFA).
■Seminar Overview
Date and Time:Tuesday, December 11, 2018 08:30 to 10:30
Venue :Grand Cube 3F, Otemachi Financial City, Global Business Hub Tokyo
Program:
08:30-08:35 Opening Remarks
Yasuhiro Suzuki(Chief Medical and Global Health Officer and Vice-Minister for Health, Ministry of Health, Labour and Welfare of Japan)
08:35-09:00 Access to Medicine Index 2018: Key Findings
Danny Edwards(Research Program Manager, Access to Medicine Foundation)
09:00-09:30 Q&A
09:30-09:40 Discussants: Building on the results of the 2018 Access to Medicine Index
Sumi Manabu(Director, Global Health Policy Division, International Cooperation Bureau, Ministry of Foreign Affairs of Japan)
Ritsuko Yamagata(Director, Health Team 2, Human Development Department, Japan International Cooperation Agency)
09:40-10:25 Discussion
10:25-10:30 Closing Remarks
Damiano de Felice(Director of Strategy, Access to Medicine Foundation)
日本語
Top Research & Recommendations Posts
- [Report and Recommendations] Discussion Points in Healthcare DX Project Expert Panel Meeting (April 2, 2024)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Event Report] Planetary Health Expert Meeting Aiming for Sustainable Healthcare: Learning from the Impact of Environmental Pollution and Medical Waste During the Pandemic (February 16, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Announcement] HGPI Joins Global Climate and Health Alliance (March 23, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Research Report] “International comparison of dementia policies, research study on information dissemination.” (April 10, 2024)
Featured Posts
-
2024-04-22
[Registration Open] (Hybrid Format) Intractable Disease Day Symposium: Future Measures for Intractable Diseases from the Perspectives of Patients and Citizens (May, 23 2024)
-
2024-04-23
[Registration Open] The 125th HGPI Seminar: Progress and Prospects for Domestic Measures on Health Problems Caused by Alcohol (May 24 , 2024)
-
2024-04-26
[Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
-
2024-05-01
[Registration Open] The Global Health Education Program (G-HEP) 2024 (May 1, 2024)
-
2024-05-02
[Announcement] Recruitment of the Health Policy Academy the 13th Session